NCT04657991 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04657991
Title	A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Recruitment	Active, not recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Pfizer
Indications	skin melanoma
Therapies	Pembrolizumab Binimetinib + Encorafenib + Pembrolizumab
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| SVK \| POL \| NZL \| NOR \| ITA \| ISR \| HUN \| GRC \| GBR \| FRA \| FIN \| ESP \| DEU \| CZE \| CHE \| CAN \| BRA \| BGR \| BEL \| AUT \| ARG

NCT04657991
Clinical Trial Detail